• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Enoxacin concentrations in serum and in the wall of the colon during colorectal surgery].

作者信息

Wenzel M, Sörgel F, Muth P, Kraeft H

机构信息

Krankenhaus Zehlendorf, Bereich Behring, Chirurgische Abteilung, Berlin.

出版信息

Infection. 1989;17 Suppl 1:S27-9. doi: 10.1007/BF01643633.

DOI:10.1007/BF01643633
PMID:2807561
Abstract

For successful prophylaxis of postoperative infections in colorectal surgery the administered antibiotic must reach sufficiently high concentrations in plasma and gut wall. Therefore, in ten patients receiving 400 mg enoxacin orally about 2 h prior to operation (in addition to their routine perioperative intravenous prophylaxis with amoxicillin and clavulanic acid) concentrations of enoxacin were determined by HPLC in plasma (samples were taken at the beginning of operation, time of tissue sampling and each hour during the operation) and in gut wall. We found the following plasma concentrations (mean +/- S.D.): beginning of operation 2.53 ( +/- 1.07) mg/l, 1 h later 2.08 ( +/- 0.82) mg/l, 2 h later 1.60 ( +/- 0.65) mg/l. At the time of tissue sampling (on an average 185 min after the enoxacin dose) the plasma concentration was 2.27 ( +/- 1.02) mg/l, the gut wall concentration was 3.74 ( +/- 1.58) mg/kg, the ratio between the two concentrations was 1.70 ( +/- 0.27). It seems warranted to study orally administered enoxacin (in combination with an antibiotic against anaerobes) in prophylaxis of infections after colorectal surgery.

摘要

相似文献

1
[Enoxacin concentrations in serum and in the wall of the colon during colorectal surgery].
Infection. 1989;17 Suppl 1:S27-9. doi: 10.1007/BF01643633.
2
[Enoxacin concentrations in lung tissue].[肺组织中的依诺沙星浓度]
Infection. 1989;17 Suppl 1:S21-2. doi: 10.1007/BF01643630.
3
[Enoxacin concentration in bone tissue].[骨组织中的依诺沙星浓度]
Infection. 1989;17 Suppl 1:S25-6. doi: 10.1007/BF01643632.
4
[Enoxacin concentration in seminal fluid, in prostate secretions and in prostatic adenoma tissue following oral administration or intravenous infusion].
Infection. 1989;17 Suppl 1:S30-6. doi: 10.1007/BF01643634.
5
[The diffusion of enoxacin into the prostatic fluid in the chronic prostatitis patient].
Hinyokika Kiyo. 1988 Nov;34(11):2067-9.
6
[A study on enoxacin concentration in human prostatic tissue].
Hinyokika Kiyo. 1990 Jan;36(1):101-2.
7
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.依诺沙星治疗复杂性尿路感染患者的体外活性、药代动力学、临床安全性及治疗效果
Infection. 1986;14 Suppl 3:S203-8. doi: 10.1007/BF01667844.
8
Pharmacokinetics and bioavailability of intravenous-to-oral enoxacin in elderly patients with complicated urinary tract infections.老年复杂性尿路感染患者静脉注射至口服依诺沙星的药代动力学和生物利用度
Antimicrob Agents Chemother. 1990 Oct;34(10):1966-72. doi: 10.1128/AAC.34.10.1966.
9
In vitro activity, pharmacokinetics, clinical safety and therapeutic efficacy of enoxacin in the treatment of patients with complicated urinary tract infections.依诺沙星治疗复杂性尿路感染患者的体外活性、药代动力学、临床安全性及治疗效果
Infection. 1985 Sep-Oct;13(5):219-24. doi: 10.1007/BF01667215.
10
Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prospective, randomized study. The PRODIGE Group.
J Hosp Infect. 1992 Nov;22 Suppl A:23-32. doi: 10.1016/s0195-6701(05)80004-0.

本文引用的文献

1
Enoxacin: worldwide in-vitro activity against 22451 clinical isolates.
J Antimicrob Chemother. 1984 Sep;14 Suppl C:47-55. doi: 10.1093/jac/14.suppl_c.47.
2
[Susceptibility of clinically important Bacteroides species against enoxacin-metronidazole and enoxacin-clindamycin combinations].
Infection. 1989;17 Suppl 1:S11-3. doi: 10.1007/BF01643627.
3
Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
Infection. 1989 May-Jun;17(3):160-4. doi: 10.1007/BF01644018.